An article published in Becker’s Hospital Review referenced a study published in the November 2023 issue of The American ...

Recent FDA approvals include new therapies for AD, HS, and plaque psoriasis, impacting patients with skin of color. Tapinarof cream, roflumilast foam, and delgocitinib are notable topical treatments ...

Prescription digital therapeutics (PDTs) are FDA-regulated tools that deliver evidence-based interventions via software, and ...

This study describes the current opportunities and obstacles associated with Medicare Diabetes Prevention Program implementation from the novel perspective of program suppliers across the US.

Stronger partnerships between primary care and oncology improve patient outcomes by ensuring coordinated care and addressing financial and systemic barriers, says Mark Fendrick, MD.

Reducing data silos and boosting transparency in oncology requires payer-provider trust and co-governance, according to Vishnukamal Golla, MD, MPH.

Semaglutide and tirzepatide should be considered the first-choice pharmacologic treatments for individuals living with obesity and most related complications, according to a new framework from the ...

Bariatric surgery is more cost-effective and offers better long-term outcomes than GLP-1 RAs for obesity and metabolic comorbidities. GLP-1 RAs face challenges like high costs, limited insurance ...

The FDA Thursday approved generic mifepristone 200-mg tablets (Evita Solutions), potentially paving the way for a more accessible version of the branded drug (Mifeprex; Danco Laboratories) but also ...

Among Medicare Advantage enrollees, the mortality of Hispanic enrollees in Puerto Rico was significantly higher than that of Hispanic enrollees in the US during 2010-2022.

The researchers concluded that those who younger than 3 years benefited from receiving 2 doses of IIV in the first year of influenza vaccination, receiving more protection than those who receibed 1 ...

Colon cancer recurrence risk falls below 0.5% at 6 years post-surgery, offering a practical benchmark for defining cure, according to new research.